Abbvie Inc. $7,189,957 Acelyrin, Inc. $201,500 Neumora Therapeutics, Inc. $4,392,278 Abbvie Inc. $7,189,957 Acelyrin, Inc. $201,500 Neumora Therapeutics, Inc. $4,392,278